HAP Trading’s Maravai LifeSciences MRVI Stock Holding History

HAP Trading’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,569	Closed	-$549K	–	2218
2022 Q1	$549K	Buy	+15,569	New	+$522K	0.02%	507

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

HAP Trading's MRVI Position: Q2 2022 in Review

HAP Trading sold out of Maravai LifeSciences (MRVI) in Q2 2022, closing a stake of 15,569 shares — an estimated $549K sold.

HAP Trading first reported a position in MRVI in Q1 2022 and held it in 1 quarter. The position peaked at $549K in Q1 2022. 216 funds tracked by Wall St. Rank hold MRVI as of Q2 2022.

HAP Trading reported no remaining Maravai LifeSciences position as of Q2 2022 after selling out during the quarter.
HAP Trading sold 15,569 Maravai LifeSciences shares in Q2 2022, an estimated $549K.
HAP Trading first reported a position in Maravai LifeSciences in Q1 2022 and held it in 1 quarter.
HAP Trading's Maravai LifeSciences position peaked at $549K in Q1 2022.
216 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2022.

Based on HAP Trading's 13F filing for Q2 2022, filed 12 Aug 2022.